Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 22
238
Views
11
CrossRef citations to date
0
Altmetric
Short Communications

Epigallocatechin gallate has antibacterial and antibiofilm activity in methicillin resistant and susceptible Staphylococcus aureus of different lineages in non-cytotoxic concentrations

, , ORCID Icon, , & ORCID Icon
Pages 4643-4647 | Received 30 Sep 2019, Accepted 17 Nov 2019, Published online: 09 Dec 2019
 

Abstract

Staphylococcus aureus is an opportunistic agent that can cause a variety of infections, both hospital and community-acquired. Epigallocatechin gallate (EGCG), a flavonoid present in the leaves of Camellia sinensis, has different biological activities, including antimicrobial potential. Here we evaluate the antibacterial and antibiofilm potential of EGCG in nine clinical strains of S. aureus with different genetic profile and antimicrobial susceptibilities. The minimum inhibitory concentrations (MIC) of EGCG ranged from 7.81 to 62.5 μg/mL, and bactericidal activity was observed at 4 times the MIC. Sub-inhibitory concentrations were able to inhibit biofilm production. Concentrations ≤62.5 μg/mL of EGCG were non-cytotoxic for murine macrophages. EGCG significantly reduced the mortality of infected Galleria mellonella larvae with the S. aureus, having shown relevant antibiofilm properties and efficacy in inhibiting the growth of different clinical isolates of S. aureus, thus being a promising substance for the treatment of infections caused by this agent.

Graphical Abstract

Disclosure statement

The authors declare no conflicts of interest.

Additional information

Funding

This study was partly financed by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) – Financing Code 001, Fundação de Amparo à Pesquisa do Estado do Espírito Santo (FAPES) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.